Investor Alley Inc.

Arena Pharmaceuticals Inc. & PulteGroup Inc. Trend Analysis Report: (NASDAQ: ARNA), (NYSE: PHM)

 
Repost This

New York, NY -- (SBWIRE) -- 01/24/2013 -- Arena Pharmaceuticals Inc. (NASDAQ: ARNA) is trading in the range of $8.63 and $8.92 during its latest trading session. The stock recorded the volume of 5.058 million shares so far. Its MACD and EMA charts show neutral trend. The stock had opened at $8.69 and is currently at the same level, up 0.12 percent from its previous close of $8.68. It is currently trading below its 6 days EMA of $9.78 and has its first support level at $8.65. In the intermediate time period, the stock may test $9.16 resistance level.

Arena Pharmaceuticals is a clinical stage biopharmaceutical company and is based out of California.

Find out where ARNA could be headed by getting the free full report here: http://www.wallstreetreport.net/market-scan/?symbol=ARNA

PulteGroup Inc. (NYSE: PHM) stock is currently at $20.89, up 0.22 percent from its previous close of $20.84. It has traded 6.150 million shares so far. The stock opened the session at $20.99 and touched its highest price point at $21.48. PulteGroup stock’s lowest price point for the session stood at $20.85. The stock’s MACD chart shows bullish trend in the short term. Its first support level is at $20.53.

PulteGroup offers homebuilding services. It also provides allied financial services. The company is based out of Michigan and it primarily deals in residential property development.

Find out more on PHM by getting the free full report here:
http://www.wallstreetreport.net/market-scan/?symbol=PHM

About WallStreetReport.net
WallStreetReport.net issues momentum alerts on stocks that can provide gains to day traders. WallStreetReport.net provides members with timely information and exclusive alerts on cheap and under-valued stocks in the United States with the potential to deliver gains of 100% - 200% or more. WallStreetReport.net monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals WallStreetReport.net is often in the know of several large investor awareness campaigns being deployed.

Timing is everything when trading Penny Stocks. Gain an Edge by joining the WallStreetReport.net newsletter and receiving alerts from a Pro-Active team of researchers. Wall Street Report believes traders should have a chance at successfully trading Penny Stocks and invites traders and investors to be part of the Free VIP membership.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.WallStreetReport.net

Disclosure: WallStreetReport.net is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit WallStreetreport.Net website, for complete risks and disclosures.

BlueLys, its employees, officers, directors, shareholders and affiliates, hold no positions in the above-mentioned stocks.

Contact Info:
Michael Baine
WALL STREET REPORT
info@WallStreetReport.net
347-905-5009